Equity valuation using multiples an empirical investigation /

Por Schreiner, Andreas.
Publicado em c200

Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses

Por Geerts, Paul, Martinez, Guadalupe, Schreiner, Andreas
Publicado em 2013

Dosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice

Por Peuskens, Joseph, Rubio, Gabriel, Schreiner, Andreas
Publicado em 2014

The effect of long-acting paliperidone palmitate once-monthly on negative and depressive symptoms in patients with schizophrenia switched from previous unsuccessful treatment with...

Por Schreiner, Andreas, Bergmans, Paul, Cherubin, Pierre, Hargarter, Ludger
Publicado no Ther Adv Psychopharmacol (2016)

PM479. Clinical and Functional Response to Paliperidone Palmitate in Early Schizophrenia – A Retrospective Observational Study in Newly Diagnosed Patients Treated Over a 12-Month P...

Por Schreiner, Andreas, Bergmans, Paul, Cherubin, Pierre, Hargarter, Ludger
Publicado no Int J Neuropsychopharmacol (2016)

PM480. Early schizophrenia patients treated with once-monthly paliperidone palmitate over a 12-month period - A Retrospective Observational Study

Por Schreiner, Andreas, Bergmans, Paul, Cherubin, Pierre, Hargarter, Ludger
Publicado no Int J Neuropsychopharmacol (2016)

Early onset of treatment effects with oral risperidone

Por Raedler, Thomas J, Schreiner, Andreas, Naber, Dieter, Wiedemann, Klaus
Publicado em 2007

Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

Por Olivares, José M, Sermon, Jan, Hemels, Michiel, Schreiner, Andreas
Publicado em 2013

PM481. Tolerability, safety and treatment response of flexibly-dosed paliperidone palmitate in patients hospitalized for an exacerbation of schizophrenia

Por Schreiner, Andreas, Bergmans, Paul, Cherubin, Pierre, Hargarter, Ludger, Lahaye, Marjolein
Publicado no Int J Neuropsychopharmacol (2016)

Psychiatrists’ perceptions of the clinical importance, assessment and management of patient functioning in schizophrenia in Europe, the Middle East and Africa

Por Gorwood, Philip, Burns, Tom, Juckel, Georg, Rossi, Alessandro, San, Luis, Hargarter, Ludger, Schreiner, Andreas
Publicado em 2013

Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

Por Smeraldi, Enrico, Cavallaro, Roberto, Folnegović-Šmalc, Vera, Bidzan, Leszek, Emin Ceylan, Mehmet, Schreiner, Andreas
Publicado em 2013

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Tria...

Por Gaebel, Wolfgang, Schreiner, Andreas, Bergmans, Paul, de Arce, Rosario, Rouillon, Frédéric, Cordes, Joachim, Eriksson, Lars, Smeraldi, Enrico
Publicado em 2010

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Tria...

Por Gaebel, Wolfgang, Schreiner, Andreas, Bergmans, Paul, Arce, Rosario de, Rouillon, Frédéric, Cordes, Joachim, Eriksson, Lars, Smeraldi, Enrico
Publicado em 2011

A Flexible-Dose Study of Paliperidone ER in Patients With Nonacute Schizophrenia Previously Treated Unsuccessfully With Oral Olanzapine

Por KOTLER, MOSHE, DILBAZ, NESRIN, ROSA, FERNANDA, PATERAKIS, PERIKLIS, MILANOVA, VIHRA, SMULEVICH, ANATOLY B., LAHAYE, MARJOLEIN, SCHREINER, ANDREAS
Publicado no J Psychiatr Pract (2016)

Treatment response, safety, and tolerability of paliperidone extended release treatment in patients recently diagnosed with schizophrenia

Por Helldin, Lars, Peuskens, Joseph, Vauth, Roland, Sacchetti, Emilio, bij de Weg, Haye, Herken, Hasan, Lahaye, Marjolein, Schreiner, Andreas
Publicado no Ther Adv Psychopharmacol (2015)

Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia

Por Emsley, Robin, Hargarter, Ludger, Bergmans, Paul, Uglešić, Boran, Sengül, Abdullah Cem, Petralia, Antonino, Khannanova, Angelina, Cherubin, Pierre, Schreiner, Andreas
Publicado no Neuropsychiatr Dis Treat (2017)

Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional st...

Por Schreiner, Andreas, Caspi, Asaf, Bergmans, Paul, Cherubin, Pierre, Keim, Sofia, Lara, Elsa, Pinchuk, Irina, Schuepbach, Daniel, Suleman, Sajid, Hargarter, Ludger
Publicado no Psychopharmacology (Berl) (2016)

Psychiatrists’ awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa

Por Olivares, José Manuel, Alptekin, Köksal, Azorin, Jean-Michel, Cañas, Fernando, Dubois, Vincent, Emsley, Robin, Gorwood, Philip, Haddad, Peter M, Naber, Dieter, Papageorgiou, George, Roca, Miquel, Thomas, Pierre, Martinez, Guadalupe, Schreiner, Andreas
Publicado em 2013

Nurses’ perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey

Por Emsley, Robin, Alptekin, Koksal, Azorin, Jean-Michel, Cañas, Fernando, Dubois, Vincent, Gorwood, Philip, Haddad, Peter M., Naber, Dieter, Olivares, José Manuel, Papageorgiou, Georgios, Roca, Miguel, Thomas, Pierre, Hargarter, Ludger, Schreiner, Andreas
Publicado no Ther Adv Psychopharmacol (2015)